combination immunotherapy in newly diagnosed mrcc
Published 6 years ago • 74 plays • Length 3:45Download video MP4
Download video MP3
Similar videos
-
1:14
combining immunotherapy with antiangiogenesis in rcc
-
2:42
therapeutic options in newly diagnosed mrcc
-
5:02
new therapy options in newly diagnosed mrcc
-
1:02
dr. gupta discusses combination immunotherapy in rcc
-
1:37
immunotherapy combinations improve survival in advanced renal cell carcinoma
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
5:06
treatment goals in newly diagnosed mrcc
-
0:48
rationale for combining atezolizumab/bevacizumab in mrcc
-
4:38
considerations when treating newly diagnosed mrcc
-
1:15
immunotherapy/tki combinations in advanced rcc
-
4:05
therapy selection for patients with newly diagnosed mrcc
-
1:12
dr. figlin describes the efficacy of ags-003 in mrcc
-
5:26
mrcc: impact of cabosun and checkmate-214
-
9:24
distinct cytokines predict response to immunotherapy and targeted therapy in mrcc
-
1:25
investigating immunotherapy treatment in renal cell carcinoma
-
1:03:29
rcc: current applications, controversies, and future use of immunotherapy and targeted agents
-
55:12
selecting and sequencing targeted and immunotherapy regimens for patients with rcc
-
1:25
dr. sznol on patient selection for combination therapy in mrcc